Akihiro Abe - Publications, H-index & Citations

Akihiro Abe

Nagoya University

39H指数

329论文数

6.7K被引数

收录论文 44

发表时间

ELC52: a novel megakaryocytic leukemia cell line with a CALR type 1 mutation

LEUKEMIA

IF13.4

2024-10-08

PREAI

Yamamoto, Yukiya; Iba, Sachiko; Inaguma, Yoko; Okamoto, Akinao; Abe, Akihiro

Metallic transport properties and electrostatic resistance modulations in LaNiO3 ultrathin channels electrochemically etched in electric-double-layer transistors

APPLIED PHYSICS LETTERS

IF3.6

2020-12-08

PREAI

Kan, Daisuke; Hatano, Takafumi; Abe, Akihiro; Ikuta, Hiroshi; Shimakawa, Yuichi

ETV6-LPXN Fusion Transcript Generated by t(11;12)(q12.1;p13) in a Patient With Relapsing Acute Myeloid Leukemia With NUP98-HOXA9

GENES CHROMOSOMES & CANCER

IF2.8

2015-11-06

PREAI

Abe, Akihiro; Yamamoto, Yukiya; Iba, Sachiko; Kanie, Tadaharu; Okamoto, Akinao; Tokuda, Masutaka; Inaguma, Yoko; Yanada, Masamitsu; Morishima, Satoko; Mizuta, Shuichi; Akatsuka, Yoshiki; Okamoto, Masataka; Kameyama, Toshiki; Mayeda, Akila; Emi, Nobuhiko

Clarifying the Impact of Polycomb Complex Component Disruption in Human Cancers

MOLECULAR CANCER RESEARCH

IF4.7

2014-04-14

OAAI

Yamamoto, Yukiya; Abe, Akihiro; Emi, Nobuhiko

Injectable Bone Tissue Engineering Using Expanded Mesenchymal Stem Cells

Stem Cells

IF3.6

2013-02-25

OAAI

Yamada, Yoichi; Nakamura, Sayaka; Ito, Kenji; Umemura, Eri; Hara, Kenji; Nagasaka, Tetsuro; Abe, Akihiro; Baba, Shunsuke; Furuichi, Yasushi; Izumi, Yuichi; Klein, Ophir D.; Wakabayashi, Toshihiko

Retention of CD34+ CML stem/progenitor cells during imatinib treatment and rapid decline after treatment with second-generation BCR-ABL inhibitors

LEUKEMIA

IF13.4

2012-03-19

OAAI

Minami, Y.; Abe, A.; Minami, M.; Kitamura, K.; Hiraga, J.; Mizuno, S.; Ymamoto, K.; Sawa, M.; Inagaki, Y.; Miyamura, K.; Naoe, T.

Escape of leukemia blasts from HLA-specific CTL pressure in a recipient of HLA one locus-mismatched bone marrow transplantation

CELLULAR IMMUNOLOGY

IF2.9

2012-03-01

OAAI

Kato, Tomonori; Terakura, Seitaro; Murata, Makoto; Sugimoto, Kyoko; Murase, Miho; Iriyama, Chisako; Tomita, Akihiro; Abe, Akihiro; Suzuki, Momoko; Nishida, Tetsuya; Naoe, Tomoki

The mTOR inhibitor, everolimus (RAD001), overcomes resistance to imatinib in quiescent Ph-positive acute lymphoblastic leukemia cells mTOR抑制剂依维莫司 (RAD001) 克服了静止的Ph阳性急性淋巴细胞白血病细胞对伊马替尼的耐药性

BLOOD CANCER JOURNAL

IF11.6

2011-05-13

OAAI

Kuwatsuka, Y.; Minami, M.; Minami, Y.; Sugimoto, K.; Hayakawa, F.; Miyata, Y.; Abe, A.; Goff, D. J.; Kiyoi, H.; Naoe, T.

PAX5-PML acts as a dual dominant-negative form of both PAX5 and PML

ONCOGENE

IF7.3

2011-01-10

PREAI

Kurahashi, S.; Hayakawa, F.; Miyata, Y.; Yasuda, T.; Minami, Y.; Tsuzuki, S.; Abe, A.; Naoe, T.

GATA-1 and GATA-2 binding to 3′ enhancer of WT1 gene is essential for its transcription in acute leukemia and solid tumor cell lines

LEUKEMIA

IF13.4

2009-02-12

PREAI

Furuhata, A.; Murakami, M.; Ito, H.; Gao, S.; Yoshida, K.; Sobue, S.; Kikuchi, R.; Iwasaki, T.; Takagi, A.; Kojima, T.; Suzuki, M.; Abe, A.; Naoe, T.; Murate, T.

N-Acetylglucosaminyltransferase V Regulates Extravillous Trophoblast Invasion through Glycosylation of α5β1 Integrin

ENDOCRINOLOGY

IF3.3

2009-02-01

OAAI

Yamamoto, Eiko; Ino, Kazuhiko; Miyoshi, Eiji; Inamori, Kei-ichiro; Abe, Akihiro; Sumigama, Seiji; Iwase, Akira; Kajiyama, Hiroaki; Shibata, Kiyosumi; Nawa, Akihiro; Kikkawa, Fumitaka

Acetylation of PML is involved in histone deacetylase inhibitor-mediated apoptosis

JOURNAL OF BIOLOGICAL CHEMISTRY

IF3.9

2008-09-01

OAAI

Hayakawa, Fumihiko; Abe, Akihiro; Kitabayashi, Issay; Pandolfi, Pier Paolo; Naoe, Tomoki

Prognostic analysis of aberrant somatic hypermutation of RhoH gene in diffuse large B cell lymphoma

LEUKEMIA

IF13.4

2007-04-19

PREAI

Hiraga, J.; Katsumi, A.; Iwasaki, T.; Abe, A.; Kiyoi, H.; Matsushita, T.; Kinoshita, T.; Naoe, T.

Thermodynamic characteristics of chain molecules in the nematic state:: PVT studies of main-chain liquid crystal comprising a long oxyethylene-type spacer

MACROMOLECULES

IF5.2

2007-02-08

PREAI

Abe, Akihiro; Hiejima, Toshihiro; Kobayashi, Yoshinori; Zhou, Zhiping; Nakafuku, Chitoshi

Lyn is an important component of the signal transduction pathway specific to FLT3/ITD and can be a therapeutic target in the treatment of AML with FLT3/ITD

LEUKEMIA

IF13.4

2007-01-18

OAAI

Okamoto, M.; Hayakawa, F.; Miyata, Y.; Watamoto, K.; Emi, N.; Abe, A.; Kiyoi, H.; Towatari, M.; Naoe, T.

Deregulated Syk inhibits differentiation and induces growth factor-independent proliferation of pre-B cells

JOURNAL OF EXPERIMENTAL MEDICINE

IF10.6

2006-11-27

OAAI

Wossning, Thomas; Herzog, Sebastian; Koehler, Fabian; Meixlsperger, Sonja; Kulathu, Yogesh; Mittler, Gerhard; Abe, Akihiro; Fuchs, Uta; Borkhardt, Arndt; Jumaa, Hassan

Quantitative RT-PCR analysis of sphingolipid metabolic enzymes in acute leukemia and myelodysplastic syndromes

LEUKEMIA

IF13.4

2006-09-07

PREAI

Sobue, S.; Iwasaki, T.; Sugisaki, C.; Nagata, K.; Kikuchi, R.; Murakami, M.; Takagi, A.; Kojima, T.; Banno, Y.; Akao, Y.; Nozawa, Y.; Kannagi, R.; Suzuki, M.; Abe, A.; Naoe, T.; Murate, T.

Mutations of N-RAS, FLT3 and p53 genes are not involved in the development of acute leukemia transformed from myeloproliferative diseases with JAK2 mutation

LEUKEMIA

IF13.4

2006-03-23

PREAI

Suzuki, M.; Abe, A.; Kiyoi, H.; Murata, M.; Ito, Y.; Shimada, K.; Morishita, Y.; Kinoshita, T.; Naoe, T.

The optimal cut-off point of C-reactive protein as an optional component of metabolic syndrome in Japan

CIRCULATION JOURNAL

IF3.7

2006-01-01

OAAI

Oda, E; Oohara, K; Abe, A; Veeraveedu, PT; Watanabe, K; Kato, K; Aizawa, Y